BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El-Maouche D, Arlt W, Merke DP. Congenital adrenal hyperplasia. Lancet. 2017;390:2194-2210. [PMID: 28576284 DOI: 10.1016/s0140-6736(17)31431-9] [Cited by in Crossref: 182] [Cited by in F6Publishing: 72] [Article Influence: 36.4] [Reference Citation Analysis]
Number Citing Articles
1 Espinosa Reyes TM, Collazo Mesa T, Lantigua Cruz PA, Agramonte Machado A, Domínguez Alonso E, Falhammar H. Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. BMC Endocr Disord 2020;20:165. [PMID: 33168061 DOI: 10.1186/s12902-020-00643-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tajima T. Health problems of adolescent and adult patients with 21-hydroxylase deficiency. Clin Pediatr Endocrinol 2018;27:203-13. [PMID: 30393437 DOI: 10.1297/cpe.27.203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Güran T. Latest Insights on the Etiology and Management of Primary Adrenal Insufficiency in Children. J Clin Res Pediatr Endocrinol 2017;9:9-22. [PMID: 29280740 DOI: 10.4274/jcrpe.2017.S002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
4 Zetterström RH, Karlsson L, Falhammar H, Lajic S, Nordenström A. Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. Int J Neonatal Screen 2020;6:E71. [PMID: 33239597 DOI: 10.3390/ijns6030071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Al Alawi AM, Nordenström A, Falhammar H. Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency. Endocrine 2019;63:407-21. [PMID: 30719691 DOI: 10.1007/s12020-018-01835-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
6 Arriba M, Ezquieta B. Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach. Front Endocrinol 2022;13:834549. [DOI: 10.3389/fendo.2022.834549] [Reference Citation Analysis]
7 Rosli NA, Mazapuspavina MY, Mohd Nor NS. Congenital Adrenal Hyperplasia: Diagnostic Pitfalls in Prolonged Neonatal Jaundice. Clin Pract 2021;11:870-7. [PMID: 34842633 DOI: 10.3390/clinpract11040102] [Reference Citation Analysis]
8 Duan L, Shen R, Song L, Liao Y, Zheng H. A novel chimeric CYP11B2/CYP11B1 combined with a new p.L340P CYP11B1 mutation in a patient with 11OHD: case report. BMC Endocr Disord 2018;18:23. [PMID: 29703198 DOI: 10.1186/s12902-018-0249-z] [Reference Citation Analysis]
9 Feng X, Kline G. Massive adrenal incidentalomas and late diagnosis of congenital adrenal hyperplasia in prostate cancer. Endocrinol Diabetes Metab Case Rep 2017;2017:17-0108. [PMID: 29118987 DOI: 10.1530/EDM-17-0108] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Obermayer-Pietsch B, de Ramon M, Reichmuth C, Bendig G, Hutzler S, Taibon J, Rank CM, Findeisen P. Multicenter Evaluation of a New, Fully Automated Androstenedione Electrochemiluminescence Immunoassay: Precision Analysis, Method Comparison, and Determination of Reference Ranges. J Appl Lab Med 2021:jfab107. [PMID: 34662384 DOI: 10.1093/jalm/jfab107] [Reference Citation Analysis]
11 Hathi D, Goswami S, Sengupta N, Acharya S, Kumar S, Talwar D. Myriad Manifestations of 3-Beta-Hydroxysteroid Dehydrogenase 2 Deficiency—A Tale of Two Infants. Cureus. [DOI: 10.7759/cureus.21779] [Reference Citation Analysis]
12 Kocova M, Concolino P, Falhammar H. Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. Front Endocrinol 2022;12:788812. [DOI: 10.3389/fendo.2021.788812] [Reference Citation Analysis]
13 Xu C, Jia W, Cheng X, Ying H, Chen J, Xu J, Guan Q, Zhou X, Zheng D, Li G, Zhao J. Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency. Mol Genet Genomic Med 2019;7:e671. [PMID: 30968594 DOI: 10.1002/mgg3.671] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
14 Fan DB, Li L, Zhang HH. Nonsense variant of NR0B1 causes hormone disorders associated with congenital adrenal hyperplasia. Sci Rep 2021;11:16066. [PMID: 34373561 DOI: 10.1038/s41598-021-95642-y] [Reference Citation Analysis]
15 Estermann MA, Smith CA. Applying Single-Cell Analysis to Gonadogenesis and DSDs (Disorders/Differences of Sex Development). Int J Mol Sci 2020;21:E6614. [PMID: 32927658 DOI: 10.3390/ijms21186614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Ku EJ, Lee C, Shim J, Lee S, Kim KA, Kim SW, Rhee Y, Kim HJ, Lim JS, Chung CH, Chun SW, Yoo SJ, Ryu OH, Cho HC, Hong AR, Ahn CH, Kim JH, Choi MH. Metabolic Subtyping of Adrenal Tumors: Prospective Multi-Center Cohort Study in Korea. Endocrinol Metab (Seoul) 2021;36:1131-41. [PMID: 34674508 DOI: 10.3803/EnM.2021.1149] [Reference Citation Analysis]
17 Lee HI, Kwon A, Suh JH, Choi HS, Song KC, Chae HW, Kim HS. Two cases of 17α-hydroxylase/17,20-lyase deficiency caused by the CYP17A1 mutation. Ann Pediatr Endocrinol Metab 2021;26:66-70. [PMID: 33819959 DOI: 10.6065/apem.2040184.092] [Reference Citation Analysis]
18 Krysiak R, Kowalcze K, Marek B, Okopień B. Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia. Acta Cardiol 2020;75:705-10. [PMID: 31538536 DOI: 10.1080/00015385.2019.1666964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wall E, Aksglaede L, Haahr ME, Christiansen P, Main KM. Non-Classic Congenital Adrenal Hyperplasia in Two Adolescents With Gender Dysphoria. Journal of Psychosexual Health 2021;3:275-9. [DOI: 10.1177/26318318211028722] [Reference Citation Analysis]
20 Kolli V, Kim H, Rao H, Lao Q, Gaynor A, Milner JD, Merke DP. Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-X. BMC Res Notes 2019;12:711. [PMID: 31666125 DOI: 10.1186/s13104-019-4753-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
21 El-Maouche D, Merke DP, Vogiatzi MG, Chang AY, Turcu AF, Joyal EG, Lin VH, Weintraub L, Plaunt MR, Mohideen P, Auchus RJ. A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2020;105:dgaa381. [PMID: 32589738 DOI: 10.1210/clinem/dgaa381] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
22 Papi G, Paragliola RM, Concolino P, Di Donato C, Pontecorvi A, Corsello SM. 46,XY Disorder of Sex Development Caused by 17α-Hydroxylase/17,20-Lyase Deficiency due to Homozygous Mutation of CYP17A1 Gene: Consequences of Late Diagnosis. Case Rep Endocrinol 2018;2018:2086861. [PMID: 29854486 DOI: 10.1155/2018/2086861] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
23 Pan P, Zheng L, Chen X, Huang J, Yang D, Li Y. Successful live birth in a Chinese woman with P450 oxidoreductase deficiency through frozen-thawed embryo transfer: a case report with review of the literature. J Ovarian Res 2021;14:22. [PMID: 33526062 DOI: 10.1186/s13048-021-00778-0] [Reference Citation Analysis]
24 Bergeron ME, Stefanov A, Haston CK. Fine mapping of the major bleomycin-induced pulmonary fibrosis susceptibility locus in mice. Mamm Genome 2018;29:670-9. [PMID: 30173367 DOI: 10.1007/s00335-018-9774-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Pofi R, Tomlinson JW. Glucocorticoids in pregnancy. Obstet Med 2020;13:62-9. [PMID: 32714437 DOI: 10.1177/1753495X19847832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
26 May T, Yi KLJ, Loveland KL, Vollenhoven B, Williams K. Overlap of autism and conditions associated with atypical sex hormone levels or response: A systematic review and meta-analysis. Research in Autism Spectrum Disorders 2021;80:101693. [DOI: 10.1016/j.rasd.2020.101693] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
27 Espinosa Reyes TM, Collazo Mesa T, Lantigua Cruz PA, Agramonte Machado A, Domínguez Alonso E, Falhammar H. Genotype-Phenotype Correlation in Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Cuba. Int J Endocrinol 2021;2021:9316284. [PMID: 33505466 DOI: 10.1155/2021/9316284] [Reference Citation Analysis]
28 Umino S, Kitamura M, Katoh-Fukui Y, Fukami M, Usui T, Yatsuga S, Koga Y. A case of combined 21-hydroxylase deficiency and CHARGE syndrome featuring micropenis and cryptorchidism. Mol Genet Genomic Med 2019;7:e730. [PMID: 31060112 DOI: 10.1002/mgg3.730] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Delai A, Gomes PM, Foss-Freitas MC, Elias J, Antonini SR, Castro M, Moreira AC, Mermejo LM. Hyperinsulinemic-euglycaemic clamp strengthens the insulin resistance in nonclassical congenital adrenal hyperplasia. J Clin Endocrinol Metab 2021:dgab767. [PMID: 34693966 DOI: 10.1210/clinem/dgab767] [Reference Citation Analysis]
30 Khorashad BS, Roshan GM, Reid AG, Aghili Z, Moghadam MD, Khazai B, Hiradfar M, Afkhamizadeh M, Ghaemi N, Talaei A, Abbaszadegan MR, Aarabi A, Dastmalchi S, Van de Grift TC. Childhood Sex-Typed Behavior and Gender Change in Individuals with 46,XY and 46,XX Disorders of Sex Development: An Iranian Multicenter Study. Arch Sex Behav 2018;47:2287-98. [PMID: 30128981 DOI: 10.1007/s10508-018-1281-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
31 Gaudino R, Pecoraro L, Martini L, Salvottini C, Antoniazzi F, Piacentini G, Cavarzere P. 21-hydroxylase-deficient congenital adrenal hyperplasia classic form therapy knowledge and management: targeted educational intervention for pediatricians. Minerva Pediatr (Torino) 2021;73:285-7. [PMID: 32241101 DOI: 10.23736/S2724-5276.20.05594-2] [Reference Citation Analysis]
32 Anastasovska V, Kocova M, Zdraveska N, Stojiljkovic M, Skakic A, Klaassen K, Pavlovic S. A novel 9 bp deletion (c.1271_1279delGTGCCCGCG) in exon 10 of CYP21A2 gene causing severe congenital adrenal hyperplasia. Endocrine 2021;73:196-202. [PMID: 33715135 DOI: 10.1007/s12020-021-02680-7] [Reference Citation Analysis]
33 Liu Y, Lyu Y, Wang H. TRP Channels as Molecular Targets to Relieve Endocrine-Related Diseases. Front Mol Biosci 2022;9:895814. [DOI: 10.3389/fmolb.2022.895814] [Reference Citation Analysis]
34 Li Z, Liang Y, Du C, Yu X, Hou L, Wu W, Ying Y, Luo X. Clinical applications of genetic analysis and liquid chromatography tandem-mass spectrometry in rare types of congenital adrenal hyperplasia. BMC Endocr Disord 2021;21:237. [PMID: 34823514 DOI: 10.1186/s12902-021-00901-8] [Reference Citation Analysis]
35 Weger M, Weger BD, Görling B, Poschet G, Yildiz M, Hell R, Luy B, Akcay T, Güran T, Dickmeis T, Müller F, Krone N. Glucocorticoid deficiency causes transcriptional and post-transcriptional reprogramming of glutamine metabolism. EBioMedicine 2018;36:376-89. [PMID: 30266295 DOI: 10.1016/j.ebiom.2018.09.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
36 Arteaga E, Valenzuela F, Lagos CF, Lagos M, Martinez A, Baudrand R, Carvajal C, Fardella CE. Detection of a novel severe mutation affecting the CYP21A2 gene in a Chilean male with salt wasting congenital adrenal hyperplasia. Endocrine 2020;67:258-63. [PMID: 31571129 DOI: 10.1007/s12020-019-02097-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Jayakrishnan R, Lao Q, Adams SD, Ward WW, Merke DP. Revisiting the association of HLA alleles and haplotypes with CYP21A2 mutations in a large cohort of patients with congenital adrenal hyperplasia. Gene 2019;687:30-4. [PMID: 30419250 DOI: 10.1016/j.gene.2018.11.023] [Reference Citation Analysis]
38 Neocleous V, Fanis P, Phylactou LA, Skordis N. Genotype Is Associated to the Degree of Virilization in Patients With Classic Congenital Adrenal Hyperplasia. Front Endocrinol (Lausanne) 2018;9:733. [PMID: 30559721 DOI: 10.3389/fendo.2018.00733] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
39 Concolino P, Paragliola RM. Molecular Analysis of 21-Hydroxylase Deficiency Reveals Two Novel Severe Genotypes in Affected Newborns. Mol Diagn Ther 2021;25:327-37. [PMID: 33710594 DOI: 10.1007/s40291-021-00520-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Hashemi Dehkordi E, Khaheshi S, Mostofizadeh N, Hashemipour M. Cardiovascular Risk Factors in Children and Adolescents with Congenital Adrenal Hyperplasia. Adv Biomed Res 2021;10:19. [PMID: 34476227 DOI: 10.4103/abr.abr_219_20] [Reference Citation Analysis]
41 Ning D, Zhang Z, Qiu K, Lu L, Zhang Q, Zhu Y, Wang R. Efficacy of intelligent diagnosis with a dynamic uncertain causality graph model for rare disorders of sex development. Front Med 2020;14:498-505. [PMID: 32681210 DOI: 10.1007/s11684-020-0791-8] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
42 Ngo Um SS, Betoko RM, Mekone I, Chetcha AB, Tardy V, Dahoun S, Mure PY, Plotton I, Morel Y, Etoga ME, Nengom JT, Moifo B, Tambo FM, Sobngwi E, Ndombo PK. Clinical, biochemical, and biomolecular aspects of congenital adrenal hyperplasia in a group of Cameroonian children and adolescents. J Pediatr Endocrinol Metab 2022. [PMID: 35499511 DOI: 10.1515/jpem-2021-0696] [Reference Citation Analysis]
43 Grecsó N, Zádori A, Szécsi I, Baráth Á, Galla Z, Bereczki C, Monostori P. Storage stability of five steroids and in dried blood spots for newborn screening and retrospective diagnosis of congenital adrenal hyperplasia. PLoS One 2020;15:e0233724. [PMID: 32470014 DOI: 10.1371/journal.pone.0233724] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
44 Johnston ZC, Bellingham M, Filis P, Soffientini U, Hough D, Bhattacharya S, Simard M, Hammond GL, King P, O'Shaughnessy PJ, Fowler PA. The human fetal adrenal produces cortisol but no detectable aldosterone throughout the second trimester. BMC Med 2018;16:23. [PMID: 29429410 DOI: 10.1186/s12916-018-1009-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
45 Corredor B, Dattani M, Gertosio C, Bozzola M. Tall Stature: A Challenge for Clinicians. Curr Pediatr Rev 2019;15:10-21. [PMID: 30394212 DOI: 10.2174/1573396314666181105092917] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Mañas-Martínez AB, Morillo-Vanegas D, Bermúdez-Cameo R, Marcos-Mondón S. Obesity secondary to endocrinology syndrome in a polymorbid patient. Rev Clin Esp (Barc) 2022:S2254-8874(22)00040-6. [PMID: 35624023 DOI: 10.1016/j.rceng.2022.02.006] [Reference Citation Analysis]
47 Ekbom K, Strandqvist A, Lajic S, Hirschberg AL, Falhammar H, Nordenström A. Assessment of medication adherence in children and adults with congenital adrenal hyperplasia and the impact of knowledge and self-management. Clin Endocrinol (Oxf) 2021;94:753-64. [PMID: 33346381 DOI: 10.1111/cen.14398] [Reference Citation Analysis]
48 Karaoğlan M, Nacarkahya G, Aytaç EH, Keskin M. Challenges of CYP21A2 genotyping in children with 21-hydroxylase deficiency: determination of genotype-phenotype correlation using next generation sequencing in Southeastern Anatolia. J Endocrinol Invest 2021. [PMID: 33677812 DOI: 10.1007/s40618-021-01546-z] [Reference Citation Analysis]
49 Ding X, Jia N, Zhao C, Zhong Y, Dai D, Zhao Y, Xu C, Cai J, Wang Q, He Q. A family with Liddle's syndrome caused by a new c.1721 deletion mutation in the epithelial sodium channel β-subunit. Exp Ther Med 2019;17:2777-84. [PMID: 30930974 DOI: 10.3892/etm.2019.7270] [Reference Citation Analysis]
50 Dubinski I, Bechtold Dalla-Pozza S, Bidlingmaier M, Reisch N, Schmidt H. Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 2021;34:1543-8. [PMID: 34523293 DOI: 10.1515/jpem-2021-0540] [Reference Citation Analysis]
51 Rudnicka E, Kunicki M, Suchta K, Machura P, Grymowicz M, Smolarczyk R. Inflammatory Markers in Women with Polycystic Ovary Syndrome. Biomed Res Int 2020;2020:4092470. [PMID: 32219132 DOI: 10.1155/2020/4092470] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
52 Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A. Hypokalemia: a clinical update. Endocr Connect 2018;7:R135-46. [PMID: 29540487 DOI: 10.1530/EC-18-0109] [Cited by in Crossref: 61] [Cited by in F6Publishing: 19] [Article Influence: 15.3] [Reference Citation Analysis]
53 Verhees MJM, Engels M, Span PN, Sweep FCGJ, van Herwaarden AE, Falhammar H, Nordenström A, Webb EA, Richter-Unruh A, Bouvattier C, de la Perrière AB, Arlt W, Reisch N, Köhler B, Rapp M, Stikkelbroeck NMML, Roeleveld N, Claahsen-van der Grinten HL. Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. Front Endocrinol (Lausanne) 2021;12:626646. [PMID: 33815285 DOI: 10.3389/fendo.2021.626646] [Reference Citation Analysis]
54 Rangaswamaiah S, Gangathimmaiah V, Nordenstrom A, Falhammar H. Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2020;11:493. [PMID: 32903805 DOI: 10.3389/fendo.2020.00493] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 Whittle E, Falhammar H. Glucocorticoid Regimens in the Treatment of Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis. J Endocr Soc 2019;3:1227-45. [PMID: 31187081 DOI: 10.1210/js.2019-00136] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
56 Bialk ER, Lasarev MR, Held PK. Wisconsin's Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia. Int J Neonatal Screen 2019;5:33. [PMID: 33072992 DOI: 10.3390/ijns5030033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
57 Chatziaggelou A, Sakkas EG, Votino R, Papagianni M, Mastorakos G. Assisted Reproduction in Congenital Adrenal Hyperplasia. Front Endocrinol (Lausanne) 2019;10:723. [PMID: 31708872 DOI: 10.3389/fendo.2019.00723] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
58 Hoyer-Kuhn H, Huebner A, Richter-Unruh A, Bettendorf M, Rohrer T, Kapelari K, Riedl S, Mohnike K, Dörr HG, Roehl FW, Fink K, Holl RW, Woelfle J. Hydrocortisone dosing in children with classic congenital adrenal hyperplasia: results of the German/Austrian registry. Endocr Connect 2021;10:561-9. [PMID: 33909597 DOI: 10.1530/EC-21-0023] [Reference Citation Analysis]
59 Kolli V, Kim H, Torky A, Lao Q, Tatsi C, Mallappa A, Merke DP. Characterization of the CYP11A1 Nonsynonymous Variant p.E314K in Children Presenting With Adrenal Insufficiency. J Clin Endocrinol Metab 2019;104:269-76. [PMID: 30299480 DOI: 10.1210/jc.2018-01661] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
60 Idkowiak J, Elhassan YS, Mannion P, Smith K, Webster R, Saraff V, Barrett TG, Shaw NJ, Krone N, Dias RP, Kershaw M, Kirk JM, Högler W, Krone RE, O'Reilly MW, Arlt W. Causes, patterns and severity of androgen excess in 487 consecutively recruited pre- and post-pubertal children. Eur J Endocrinol 2019;180:213-21. [PMID: 30566905 DOI: 10.1530/EJE-18-0854] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
61 Lolis E, Juhlin CC, Nordenström A, Falhammar H. Extensive Bilateral Adrenal Rest Testicular Tumors in a Patient With 3β-Hydroxysteroid Dehydrogenase Type 2 Deficiency. J Endocr Soc 2018;2:513-7. [PMID: 29850650 DOI: 10.1210/js.2018-00082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Collaer ML, Hines M. No Evidence for Enhancement of Spatial Ability with Elevated Prenatal Androgen Exposure in Congenital Adrenal Hyperplasia: A Meta-Analysis. Arch Sex Behav 2020;49:395-411. [DOI: 10.1007/s10508-020-01645-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
63 Kinaan M, Hamidi O, Yau H, Courtney KD, Eraslan A, Simon K. Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer. J Endocr Soc 2021;5:bvaa158. [PMID: 33294761 DOI: 10.1210/jendso/bvaa158] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Lee BR, Strobel KM, Chu A. The Neonate with Ambiguous Genitalia. Neoreviews 2021;22:e241-9. [PMID: 33795399 DOI: 10.1542/neo.22-4-e241] [Reference Citation Analysis]
65 Alla A, Draoui N, Rami I, Rouf S, Saadi H, Kamaoui I, Latrech H. A rare case report about a congenital adrenal hyperplasia by 21-hydroxylase lock in its pure virilizing form discovered in adolescence. Annals of Medicine and Surgery 2022;78:103673. [DOI: 10.1016/j.amsu.2022.103673] [Reference Citation Analysis]
66 Sarfati J, Vatier C, Keller I, Guéchot J, Bellanné-Chantelot C, Christin-Maitre S. Severe Congenital Adrenal Hyperplasia Presenting as Bilateral Testicular Tumors and Azoospermia in the Third Decade of Life. J Endocr Soc 2018;2:997-1000. [PMID: 30140784 DOI: 10.1210/js.2018-00103] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Dahl SR, Nermoen I, Brønstad I, Husebye ES, Løvås K, Thorsby PM. Assay of steroids by liquid chromatography-tandem mass spectrometry in monitoring 21-hydroxylase deficiency. Endocr Connect 2018;7:1542-50. [PMID: 30530876 DOI: 10.1530/EC-18-0453] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
68 Villela D, Che H, Van Ghelue M, Dehaspe L, Brison N, Van Den Bogaert K, Devriendt K, Lewi L, Bayindir B, Vermeesch JR. Fetal sex determination in twin pregnancies using non-invasive prenatal testing. NPJ Genom Med 2019;4:15. [PMID: 31285848 DOI: 10.1038/s41525-019-0089-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
69 Baronio F, Ortolano R, Menabò S, Cassio A, Baldazzi L, Di Natale V, Tonti G, Vestrucci B, Balsamo A. 46,XX DSD due to Androgen Excess in Monogenic Disorders of Steroidogenesis: Genetic, Biochemical, and Clinical Features. Int J Mol Sci 2019;20:E4605. [PMID: 31533357 DOI: 10.3390/ijms20184605] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
70 Dörr HG, Penger T, Albrecht A, Marx M, Völkl TMK. Birth Size in Neonates with Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency. J Clin Res Pediatr Endocrinol 2019;11:41-5. [PMID: 30178749 DOI: 10.4274/jcrpe.galenos.2018.2018.0149] [Reference Citation Analysis]
71 Liedmeier A, Jendryczko D, Rapp M, Roehle R, Thyen U, Kreukels BP. The influence of psychosocial and sexual wellbeing on quality of life in women with differences of sexual development. Comprehensive Psychoneuroendocrinology 2021;8:100087. [DOI: 10.1016/j.cpnec.2021.100087] [Reference Citation Analysis]
72 Balsamo A, Baronio F, Ortolano R, Menabo S, Baldazzi L, Di Natale V, Vissani S, Cassio A. Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant. Front Pediatr 2020;8:593315. [PMID: 33415088 DOI: 10.3389/fped.2020.593315] [Reference Citation Analysis]
73 Kocova M, Anastasovska V, Falhammar H. Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine 2020;69:262-77. [PMID: 32367336 DOI: 10.1007/s12020-020-02323-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
74 Improda N, Barbieri F, Ciccarelli GP, Capalbo D, Salerno M. Cardiovascular Health in Children and Adolescents With Congenital Adrenal Hyperplasia Due to 21-Hydroxilase Deficiency. Front Endocrinol (Lausanne) 2019;10:212. [PMID: 31031703 DOI: 10.3389/fendo.2019.00212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
75 Calcaterra V, Bassanese F, Clemente AM, Amariti R, Regalbuto C, Sala A, Zuccotti GV. Adverse Effects of Ramadan Fasting in a Girl with Salt-Losing Congenital Adrenal Hyperplasia. Case Rep Endocrinol 2020;2020:6688927. [PMID: 33457025 DOI: 10.1155/2020/6688927] [Reference Citation Analysis]
76 Rehnitz J. Genetische Grundlagen bei Varianten der Geschlechtsentwicklung. Gynäkologische Endokrinologie 2021;19:11-8. [DOI: 10.1007/s10304-020-00359-2] [Reference Citation Analysis]
77 Daae E, Feragen KB, Waehre A, Nermoen I, Falhammar H. Sexual Orientation in Individuals With Congenital Adrenal Hyperplasia: A Systematic Review. Front Behav Neurosci 2020;14:38. [PMID: 32231525 DOI: 10.3389/fnbeh.2020.00038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
78 Carrozza C, Foca L, De Paolis E, Concolino P. Genes and Pseudogenes: Complexity of the RCCX Locus and Disease. Front Endocrinol (Lausanne) 2021;12:709758. [PMID: 34394006 DOI: 10.3389/fendo.2021.709758] [Reference Citation Analysis]
79 Hamed SA, Attiah FA, Abd Elaal RF, Fawzy M. Behavioral assessment of females with congenital adrenal hyperplasia. Hormones (Athens) 2021;20:131-41. [PMID: 32740726 DOI: 10.1007/s42000-020-00232-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
80 Nikitina I, Kudryashova E, Kelmanson I. Prenatal androgen exposure and gender behavior in disorders of sex development. Sexologies 2021. [DOI: 10.1016/j.sexol.2021.04.006] [Reference Citation Analysis]
81 Gehrmann K, Engels M, Bennecke E, Bouvattier C, Falhammar H, Kreukels BPC, Nordenstrom A, Reisch N, Gehrmann N, Stikkelbroeck NMML, Quinkler M, Claahsen-van der Grinten HL; dsd-LIFE group. Sexuality in Males With Congenital Adrenal Hyperplasia Resulting From 21-Hydroxylase Deficiency. J Endocr Soc 2019;3:1445-56. [PMID: 31317123 DOI: 10.1210/js.2019-00082] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
82 Ferreira MJ, Moita R, Canha M, Ferreira S, Costa C, Almeida P, Castedo JL, Carvalho D, Castro-Correia C. Quality of Life in Children Diagnosed With Non-classic Congenital Adrenal Hyperplasia. Cureus 2021;13:e18937. [PMID: 34812321 DOI: 10.7759/cureus.18937] [Reference Citation Analysis]
83 Wawrzkiewicz-Jałowiecka A, Lalik A, Soveral G. Recent Update on the Molecular Mechanisms of Gonadal Steroids Action in Adipose Tissue. Int J Mol Sci 2021;22:5226. [PMID: 34069293 DOI: 10.3390/ijms22105226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Wang X, Wang Y, Ma D, Zhang Z, Li Y, Yang P, Sun Y, Jiang T. Neonatal Screening and Genotype-Phenotype Correlation of 21-Hydroxylase Deficiency in the Chinese Population. Front Genet 2020;11:623125. [PMID: 33552137 DOI: 10.3389/fgene.2020.623125] [Reference Citation Analysis]
85 Haller M, Ma L. Temporal, spatial, and genetic regulation of external genitalia development. Differentiation 2019;110:1-7. [PMID: 31521888 DOI: 10.1016/j.diff.2019.08.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Held PK, Bialk ER, Lasarev MR, Allen DB. 21-Deoxycortisol is a Key Screening Marker for 21-Hydroxylase Deficiency. J Pediatr 2021:S0022-3476(21)01063-5. [PMID: 34780778 DOI: 10.1016/j.jpeds.2021.10.063] [Reference Citation Analysis]
87 Mallappa A, Nella AA, Sinaii N, Rao H, Gounden V, Perritt AF, Kumar P, Ling A, Liu CY, Soldin SJ, Merke DP. Long-term use of continuous subcutaneous hydrocortisone infusion therapy in patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2018;89:399-407. [PMID: 30003563 DOI: 10.1111/cen.13813] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
88 Navardauskaitė R, Banevičiūtė K, Songailienė J, Grigalionienė K, Čereškevičius D, Šukys M, Mockevicienė G, Smirnova M, Utkus A, Verkauskienė R. Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia. Medicina (Kaunas) 2021;57:1035. [PMID: 34684072 DOI: 10.3390/medicina57101035] [Reference Citation Analysis]
89 Held PK, Bird IM, Heather NL. Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy. Int J Neonatal Screen 2020;6:67. [PMID: 33117906 DOI: 10.3390/ijns6030067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
90 Mikhail ME, Anaya C, Culbert KM, Sisk CL, Johnson A, Klump KL. Gonadal Hormone Influences on Sex Differences in Binge Eating Across Development. Curr Psychiatry Rep 2021;23:74. [PMID: 34613500 DOI: 10.1007/s11920-021-01287-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Baranowski ES, Arlt W, Idkowiak J. Monogenic Disorders of Adrenal Steroidogenesis. Horm Res Paediatr 2018;89:292-310. [PMID: 29874650 DOI: 10.1159/000488034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
92 Grecsó N, Zádori A, Baráth Á, Galla Z, Rácz G, Bereczki C, Monostori P. Comparison of different preparation techniques of dried blood spot quality controls in newborn screening for congenital adrenal hyperplasia. PLoS One 2021;16:e0252091. [PMID: 34015037 DOI: 10.1371/journal.pone.0252091] [Reference Citation Analysis]
93 Handelsman DJ, Hirschberg AL, Bermon S. Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance. Endocr Rev 2018;39:803-29. [PMID: 30010735 DOI: 10.1210/er.2018-00020] [Cited by in Crossref: 93] [Cited by in F6Publishing: 74] [Article Influence: 31.0] [Reference Citation Analysis]
94 Chen Cardenas SM, El-Kaissi S, Jarad O, Liaqat M, Korbonits M, Hamrahian AH. Unusual Combination of MEN-1 and the Contiguous Gene Deletion Syndrome of CAH and Ehlers-Danlos Syndrome (CAH-X). J Endocr Soc 2020;4:bvaa077. [PMID: 32715272 DOI: 10.1210/jendso/bvaa077] [Reference Citation Analysis]
95 Daae E, Feragen KB, Nermoen I, Falhammar H. Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review. Endocrine 2018;62:3-13. [PMID: 30128958 DOI: 10.1007/s12020-018-1723-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
96 Unluhizarci K, Karaca Z, Kelestimur F. Role of insulin and insulin resistance in androgen excess disorders. World J Diabetes 2021; 12(5): 616-629 [PMID: 33995849 DOI: 10.4239/wjd.v12.i5.616] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Storbeck KH, Schiffer L, Baranowski ES, Chortis V, Prete A, Barnard L, Gilligan LC, Taylor AE, Idkowiak J, Arlt W, Shackleton CHL. Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism. Endocr Rev 2019;40:1605-25. [PMID: 31294783 DOI: 10.1210/er.2018-00262] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 12.5] [Reference Citation Analysis]
98 El-Maouche D, Hannah-Shmouni F, Mallappa A, Hargreaves CJ, Avila NA, Merke DP. Adrenal morphology and associated comorbidities in congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2019;91:247-55. [PMID: 31001843 DOI: 10.1111/cen.13996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
99 Pellegrino F, Scabbia F, Merlo A, Perrucci L, Aliberti L, Urso A, Ambrosio MR, Cuneo A, Galeotti R, Giganti M. Spontaneously reversible adrenal nodules in primary diffuse large B-cell testicular lymphoma mimicking an extranodal involvement: A case report. Radiol Case Rep 2021;16:2168-73. [PMID: 34168717 DOI: 10.1016/j.radcr.2021.05.034] [Reference Citation Analysis]
100 Elliott V, Waldrop SW, Wiromrat P, Carreau AM, Green MC. The Interaction of Obesity and Reproductive Function in Adolescents. Semin Reprod Med 2022. [PMID: 35562099 DOI: 10.1055/s-0042-1744495] [Reference Citation Analysis]
101 Falhammar H, Frisén L, Hirschberg AL, Nordenskjöld A, Almqvist C, Nordenström A. Increased Risk of Autoimmune Disorders in 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study. J Endocr Soc 2019;3:1039-52. [PMID: 31065621 DOI: 10.1210/js.2019-00122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
102 Gong Y, Qin F, Li WJ, Li LY, He P, Zhou XJ. Cytochrome P450 family 17 subfamily A member 1 mutation causes severe pseudohermaphroditism: A case report. World J Clin Cases 2022; 10(11): 3553-3560 [DOI: 10.12998/wjcc.v10.i11.3553] [Reference Citation Analysis]
103 Berry V, Pontikos N, Ionides A, Kalitzeos A, Quinlan RA, Michaelides M. Pathogenic variants in the CYP21A2 gene cause isolated autosomal dominant congenital posterior polar cataracts. Ophthalmic Genet 2021;:1-6. [PMID: 34748434 DOI: 10.1080/13816810.2021.1998556] [Reference Citation Analysis]
104 Seneviratne SN, Sandakelum U, Jayawardena CH, Weerasinghe AM, Wickramarachchi PS, de Silva S. Presenting status of children with classical congenital adrenal hyperplasia over two decades (1999-2018) in the absence of newborn screening in Sri Lanka. J Pediatr Endocrinol Metab 2021;34:1131-7. [PMID: 34192833 DOI: 10.1515/jpem-2020-0681] [Reference Citation Analysis]
105 Lai F, Srinivasan S, Wiley V. Evaluation of a Two-Tier Screening Pathway for Congenital Adrenal Hyperplasia in the New South Wales Newborn Screening Programme. Int J Neonatal Screen 2020;6:63. [PMID: 33117905 DOI: 10.3390/ijns6030063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]